- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- March 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 184 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- January 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- September 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2025
- 880 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- December 2024
- 122 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Report
- October 2024
- 140 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- December 2024
- 134 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Clinical Trials
- November 2024
- 450 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- August 2024
- 265 Pages
Global
From €7236EUR$7,950USD£6,146GBP

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more